Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autonomic Nervous System Dysfunction in Parkinson's Disease.

Theresa A. Zesiewicz1, Matthew J. Baker, Mervat Wahba

  • 1*Parkinson's Disease and Movement Disorders Center, 4 Columbia Drive, Suite 410, Tampa, FL 33606, USA. tzesiewi@hsc.usf.edu

Current Treatment Options in Neurology
|March 12, 2003
PubMed
Summary

Autonomic nervous system (ANS) dysfunction affects most Parkinson's disease (PD) patients, causing various symptoms. Early recognition and targeted treatments are crucial for managing ANS dysfunction in PD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hashimoto encephalopathy with angiographic CNS vasculitis.

Neurology. Clinical practice·2018
Same author

Detection of Early Ischemic Changes in Noncontrast CT Head Improved with "Stroke Windows".

ISRN neuroscience·2014
Same author

Case report of intracranial Rosai-Dorfman disease.

Hospital practice (1995)·2013
Same author

Asterixis related to gabapentin intake: a case report and review.

Postgraduate medicine·2013
Same author

Diffuse Lewy Body Disease.

Current treatment options in neurology·2001

Area of Science:

  • Neurology
  • Autonomic Neuroscience

Background:

  • Autonomic nervous system (ANS) dysfunction is a prevalent complication in Parkinson's disease (PD), impacting 70-80% of individuals.
  • Symptoms manifest diversely, including sexual, gastrointestinal, urinary, sleep, and cardiovascular issues like orthostatic hypotension.

Purpose of the Study:

  • To highlight the significant impact of ANS dysfunction in Parkinson's disease.
  • To discuss the underlying causes and management strategies for ANS dysfunction in PD patients.

Main Methods:

  • Review of existing literature on ANS dysfunction in Parkinson's disease.
  • Analysis of common symptoms, etiological factors, and treatment approaches.

Main Results:

  • ANS dysfunction presents with a wide array of symptoms, significantly affecting patient quality of life.

Related Experiment Videos

  • Degenerative processes in neural pathways and anti-Parkinsonian medications can contribute to or exacerbate ANS dysfunction.
  • Coordinated care involving neurologists and subspecialists, alongside pharmacotherapy, is essential for effective management.

    • Conclusions:

    • Recognizing and treating ANS dysfunction is vital for comprehensive Parkinson's disease care.
    • Multidisciplinary management and targeted pharmacotherapy can alleviate debilitating symptoms of ANS dysfunction in PD.